{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:23:00Z","timestamp":1785838980804,"version":"3.56.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Frankfurt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesiologie"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00101-024-01396-3","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T11:02:01Z","timestamp":1712142121000},"page":"272-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Was ist neu\u00a0\u2026\u00a0bei den Faktor-XI-Inhibitoren: DOAK\u00a02.0?","What is new\u2026for factor XI inhibitors: DOAC\u00a02.0?"],"prefix":"10.1007","volume":"73","author":[{"given":"A.","family":"Schlake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Scheiermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. F.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"1396_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.jacc.2021.06.010","volume":"78","author":"C Hsu","year":"2021","unstructured":"Hsu\u00a0C, Hutt\u00a0E, Bloomfield\u00a0DM, Gailani\u00a0D, Weitz\u00a0JI (2021) Factor XI inhibition to uncouple thrombosis from hemostasis: JACC review topic of the week. J\u00a0Am Coll Cardiol 78:625\u2013631","journal-title":"J Am Coll Cardiol"},{"key":"1396_CR2","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1160\/TH10-05-0307","volume":"105","author":"O Salomon","year":"2011","unstructured":"Salomon\u00a0O, Steinberg\u00a0DM, Zucker\u00a0M, Varon\u00a0D, Zivelin\u00a0A, Seligsohn\u00a0U (2011) Patients with severe factor\u00a0XI deficiency have a\u00a0reduced incidence of deep-vein thrombosis. Thromb Haemost 105:269\u2013273","journal-title":"Thromb Haemost"},{"key":"1396_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/a-1984-7021","volume":"43","author":"I Koulas","year":"2023","unstructured":"Koulas\u00a0I, Spyropoulos\u00a0AC (2023) A\u00a0review of FXIa inhibition as a\u00a0novel target for anticoagulation. Hamostaseologie 43:28\u201336","journal-title":"Hamostaseologie"},{"key":"1396_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(22)00456-1","volume":"399","author":"JP Piccini","year":"2022","unstructured":"Piccini\u00a0JP, Caso\u00a0V, Connolly\u00a0SJ, Fox\u00a0KAA, Oldgren\u00a0J, Jones\u00a0WS, Gorog\u00a0DA et\u00a0al (2022) Safety of the oral factor\u00a0XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a\u00a0multicentre, randomised, double-blind, double-dummy, dose-finding phase\u00a02\u00a0study. Lancet 399:1383\u20131390","journal-title":"Lancet"},{"key":"1396_CR5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/S0140-6736(22)01588-4","volume":"400","author":"A Shoamanesh","year":"2022","unstructured":"Shoamanesh\u00a0A, Mundl\u00a0H, Smith\u00a0EE, Masjuan\u00a0J, Milanov\u00a0I, Hirano\u00a0T, Agafina\u00a0A et\u00a0al (2022) Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase\u00a02b\u00a0trial. Lancet 400:997\u20131007","journal-title":"Lancet"},{"key":"1396_CR6","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1111\/jth.15890","volume":"20","author":"J Presume","year":"2022","unstructured":"Presume\u00a0J, Ferreira\u00a0J, Ribeiras\u00a0R, Mendes\u00a0M (2022) Achieving higher efficacy without compromising safety with factor\u00a0XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis. J\u00a0Thromb Haemost 20:2930\u20132938","journal-title":"J Thromb Haemost"},{"key":"1396_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12916-020-01695-7","volume":"18","author":"LM Paschke","year":"2020","unstructured":"Paschke\u00a0LM, Klimke\u00a0K, Altiner\u00a0A, von Stillfried\u00a0D, Schulz\u00a0M (2020) Comparing stroke prevention therapy of direct oral anticoagulants and vitamin\u00a0K antagonists in patients with atrial fibrillation: a\u00a0nationwide retrospective observational study. BMC Med 18:254","journal-title":"BMC Med"}],"container-title":["Die Anaesthesiologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-024-01396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00101-024-01396-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-024-01396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T10:02:39Z","timestamp":1713261759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00101-024-01396-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1396"],"URL":"https:\/\/doi.org\/10.1007\/s00101-024-01396-3","relation":{},"ISSN":["2731-6858","2731-6866"],"issn-type":[{"value":"2731-6858","type":"print"},{"value":"2731-6866","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"29 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"A.\u00a0Schlake, P.\u00a0Scheiermann und C.F.\u00a0Weber geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}